Quarter Ended Mar 31, 2021
Net sales increased 7% to a record $102.4 million compared to $95.9 million
GAAP net income increased significantly to $4.2 million, or $0.20 per diluted share, compared to $3.0 million, or $0.15 per diluted share
Adjusted EBITDA increased 20% to $11.6 million compared to $9.7 million
For complete information regarding our financials, see our periodic filings.